Europe — EMA
Ogluo (Glucagon)
Glucagon, the active ingredient in Ogluo, is a peptide hormone presented as a 1 mg/1 ml solution for subcutaneous injection use. It treats severe hypoglycaemia in people with diabetes.
Request sourcing
What is Glucagon?
Glucagon, the active ingredient in Ogluo, is a peptide hormone presented as a 1 mg/1 ml solution for subcutaneous injection use. It treats severe hypoglycaemia in people with diabetes. GNH USA supplies Ogluo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
GNH USA supplies Ogluo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Glucagon used for?
Ogluo is a peptide hormone used in the emergency management of low‑blood‑glucose conditions.
- Severe hypoglycaemia: rapidly raises blood glucose levels in diabetic patients. - Diagnostic glucagon stimulation test: assists in evaluating pancreatic endocrine function. - Beta‑cell function assessment: supports assessment of insulin secretory capacity. - Post‑operative glucose control: helps prevent hypoglycaemia after surgery. - Research laboratory use: employed in studies of glucose metabolism. - Off‑label un‑specified use of any other condition ?.
What are the side effects of Glucagon?
Glucagon administration can result …
Common Side Effects: - ... t… t....
Serious or Rare t t t t " " " " " ": d t.
t d ewline ewline ewline ...
What precautions apply to Glucagon?
Ogluo t ewline \
